Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2002 1
2003 2
2004 4
2005 4
2006 2
2007 3
2008 4
2009 4
2010 5
2011 4
2012 2
2013 5
2014 6
2015 5
2016 2
2017 8
2018 8
2019 6
2020 8
2021 5
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Canonical AREs are tumor suppressive regulatory elements in the prostate.
Augello MA, Chen X, Liu D, Lin K, Hakansson A, Sjöström M, Khani F, Deonarine LD, Liu Y, Travascio-Green J, Wu J, Loda M, Feng FY, Robinson BD, Davicioni E, Sboner A, Barbieri CE. Augello MA, et al. Among authors: liu d. bioRxiv [Preprint]. 2024 Feb 27:2024.02.23.581466. doi: 10.1101/2024.02.23.581466. bioRxiv. 2024. PMID: 38464162 Free PMC article. Preprint.
Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130.
Kwon OJ, Zhang B, Jia D, Zhang L, Wei X, Zhou Z, Liu D, Huynh KT, Zhang K, Zhang Y, Labhart P, Sboner A, Barbieri C, Haffner MC, Creighton CJ, Xin L. Kwon OJ, et al. Among authors: liu d. Oncogene. 2022 Feb;41(9):1309-1323. doi: 10.1038/s41388-021-02169-7. Epub 2022 Jan 8. Oncogene. 2022. PMID: 34999736 Free PMC article.
G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer.
Mukhopadhyay C, Yang C, Xu L, Liu D, Wang Y, Huang D, Deonarine LD, Cyrta J, Davicioni E, Sboner A, Robinson BD, Chinnaiyan AM, Rubin MA, Barbieri CE, Zhou P. Mukhopadhyay C, et al. Among authors: liu d. Nat Commun. 2021 Nov 18;12(1):6662. doi: 10.1038/s41467-021-27024-x. Nat Commun. 2021. PMID: 34795264 Free PMC article.
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity.
Grbesa I, Augello MA, Liu D, McNally DR, Gaffney CD, Huang D, Lin K, Ivenitsky D, Goueli R, Robinson BD, Khani F, Deonarine LD, Blattner M, Elemento O, Davicioni E, Sboner A, Barbieri CE. Grbesa I, et al. Among authors: liu d. Cell Rep. 2021 Sep 7;36(10):109625. doi: 10.1016/j.celrep.2021.109625. Cell Rep. 2021. PMID: 34496233 Free PMC article.
Tumor size and genomic risk in localized prostate cancer.
Gaffney C, Liu D, Cooley V, Ma X, Angulo C, Robinson B, Khani F, Cai P, Salami S, Nallandhighal S, Shoag J, Barbieri C. Gaffney C, et al. Among authors: liu d. Urol Oncol. 2021 Jul;39(7):434.e17-434.e22. doi: 10.1016/j.urolonc.2021.01.020. Epub 2021 Feb 6. Urol Oncol. 2021. PMID: 33563537
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes.
Ben-Salem S, Hu Q, Liu Y, Alshalalfa M, Zhao X, Wang I, Venkadakrishnan VB, Senapati D, Kumari S, Liu D, Sboner A, Barbieri CE, Feng F, Billaud JN, Davicioni E, Liu S, Heemers HV. Ben-Salem S, et al. Among authors: liu d. Eur Urol Open Sci. 2020 Dec;22:34-44. doi: 10.1016/j.euros.2020.10.002. Epub 2020 Nov 6. Eur Urol Open Sci. 2020. PMID: 33299986 Free PMC article.
89 results